Global Companion Diagnostics Market 2022-2028: Ongoing Research and Investments in Next Generation Gene-Sequencing Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 30, 2022--

The "Global Companion Diagnostics Market 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Market Outlook

Based on this report, the global companion diagnostics market is projected to progress with a CAGR of 12.84% during the forecast period 2022-2028.

The prominent factors fueling the global market's growth include a surge in medication reaction incidence, increasing cancer cases, and the growing use of precision medicines. Additionally, the ongoing research and investments in next generation gene-sequencing are expected to create affluent opportunities for the market.

However, a weak reimbursement framework and common cases of leakage in oncology companion diagnostics are expected to restrict the studied market's growth over the forecast period.

Regional Outlook

The global companion diagnostics market covers North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa regions.

The Asia-Pacific is anticipated to emerge as the fastest-growing region over the forecast period. The region's growth can be attributed to the tremendous growth in precision medicine technology. Moreover, initiatives undertaken to promote the R&D of precision medicine are supporting the market's growth. In this regard, diagnostic and pharma companies are collaborating to offer an international platform to facilitate access to precision medicine. Thus, as mentioned above, these factors are expected to widen the scope and growth of the companion diagnostics market in the upcoming years.

Market Dynamics

Market Drivers

• Increase in Incidence of Medication Reactions
• Increasing Prevalence of Cancer Cases and Fatalities
• Rising Prevalence of Precision Medicines

Market Challenges

• Weak Reimbursement Framework
• Common Cases of Leakage in Oncology Companion Diagnostics

Market Opportunity

• Ongoing Research and Investments in Next Generation Gene-Sequencing

Key Topics Covered:

1. Global Companion Diagnostics Market - Summary

2. Industry Outlook

3. Global Companion Diagnostics Market Outlook - by Mechanism

4. Global Companion Diagnostics Market Outlook - by Indicator

5. Global Companion Diagnostics Market Outlook - by Consumer

6. Global Companion Diagnostics Market Outlook - by Commodity

7. Global Companion Diagnostics Market - Regional Outlook

8. Competitive Landscape

9. Research Methodology & Scope

Companies Mentioned

• Abbott Laboratories
• Almac Group
• Arup Laboratories
• Biocartis
• Biomerieux
• Danaher Corporation
• GE Healthcare
• Genomic Health
• Illumina Inc
• Myriad Genetics
• Qiagen
• Roche Diagnostics
• Sysmex Corporation
• Thermo Fisher Scientific
• Agilent

For more information about this report visit https://www.researchandmarkets.com/r/jqbmgd

View source version on businesswire.com:https://www.businesswire.com/news/home/20220930005326/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.